Publications and communications of Arianna Sala

Sala, A. (08 July 2026). Towards the Neurochemical Architecture of Disorders of Consciousness (DoC) [Paper presentation]. ASSC.

Cavaliere, C., Galli, A., Meneghini, C., Severino, M., Peretti, D. E., Nørgaard, M., Tang, C., Martini, A. L., Bardiau, M., Doyen, M., Gonzalez-Escamilla, G., Horwitz, T., Perovnik, M., Rullmann, M., Talmasov, D., Volpi, T., Xu, Z., Calhoun, V., Di, X., ... Caminiti, S. P. (June 2026). Molecular connectivity studies of cerebral glucose metabolism and blood flow: A scoping review. Neuroscience and Biobehavioral Reviews, 185, 106623. doi:10.1016/j.neubiorev.2026.106623

Xu, Z., Mijalkov, M., Sun, J., Chang, Y.-W., Sala, A., Volpe, G., Severino, M., Veronese, M., Garcia-Ptacek, S., Pereira, J. B., & Alzheimer's Disease Neuroimaging Initiative. (March 2026). Mapping individual molecular connectomes in Alzheimer's disease. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 22 (3), 71310. doi:10.1002/alz.71310

Selte, A., Sanz, L., Andris, C., Thibaut, A., Larroque, S., Bernard, C., Hustinx, R., Laureys, S., Sala, A.* , & Gosseries, O. (2026). A multimodal account of visual impairments in post-coma patients. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/339410. doi:10.21203/rs.3.rs-8497586/v1

Sala, A., Meys, M., Alnagger, N., Beliy, N., Abagnale, S., Szirmai, D., Ok, B. K., Wang, Z., Bardiau, M., Beaudart, C., Eickhoff, S. B., Martins, D., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2026). Multimodal meta-analysis of brain integrity in disorders of consciousness. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/339409. doi:10.21203/rs.3.rs-8480413/v1

Gillet, A., van der Lande, G., Aubinet, C., Cardone, P., Nunez Novo, P., Alnagger, N., Annen, J., Bernard, C., Bicego, A. Y., Cecconi, B., Fritz, P., Gosseries, O., Grégoire, C., Hustinx, R., Lejeune, N., Louras, M., Maquet, N., Marie, N., Martens, G., ... Sala, A. (28 November 2025). A Protocol and Preliminary Insights for the Acquisition of a Multimodal Brain Dataset of Healthy Participants [Poster presentation]. GIGANeuro Day.

Galli, A., Inglese, M., Presotto, L., Malito, R., Di, X., Toschi, N., Pilotto, A., Padovani, A., Tassorelli, C., Perani, D., Sala, A.* , & Caminiti, S. P.*. (October 2025). Glucose metabolism in hyper-connected regions predicts neurodegeneration and speed of conversion in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 52 (12), 4639 - 4651. doi:10.1007/s00259-025-07379-9

Lizarraga, A.* , Sala, A.* , Koch, K., & Yakushev, I. (2025). Test-retest reproducibility of structural and proxy estimates of brain connectivity at rest. NeuroImage, 121558. doi:10.1016/j.neuroimage.2025.121558

Gillet, A., PALMERI, D., Bernard, C., van der Lande, G., Aubinet, C., Cardone, P., Nunez Novo, P., Alnagger, N., Annen, J., Bicego, A. Y., Cecconi, B., Fritz, P., Gosseries, O., Grégoire, C., Lejeune, N., Louras, M., Maquet, N., Marie, N., Martens, G., ... Sala, A. (12 September 2025). A protocol for the construction of a multimodal brain dataset for healthy control subjects [Poster presentation]. GIGA DAY 2025, Liège, Belgium.

Pilotto, A., Galli, A., Sala, A., Caminiti, S. P., Presotto, L., Liguori, C., Mercuri, N. B., Premi, E., Garibotto, V., Frisoni, G., Chiaravalloti, A., Schillaci, O., D'Amelio, M., Paghera, B., Lucchini, S., Bertagna, F., Perani, D., & Padovani, A. (July 2025). Dopaminergic deficits along the spectrum of Alzheimer's disease. Molecular Psychiatry, 30 (7), 3069 - 3076. doi:10.1038/s41380-025-02913-5

Sala, A. (July 2025). Searching For The Neural Correlates Of Consciousness: What Can We Learn From Global States Of Consciousness? [Paper presentation]. ASSC.

Habeck, C., Sala, A., Sossi, V., & Talmasov, D. (2025). Validating brain connectivity measures: integrating biological, statistical, and clinical evidence [Paper presentation]. OHBM, Brisbane, Australia.

Sala, A. (2025). Twenty years of research in disorders of consciousness: a meta-analysis of brain molecular, functional and structural alterations [Paper presentation]. Inauguration ceremony for the Zhejiang-Belgium Joint Laboratory for Disorders of Consciousness.

Sala, A. (2025). History of macroscale brain connectivity [Paper presentation]. Molecular Imaging of Brain Connectivity: towards standardized nomenclature, Munich, Germany.

Sala, A. (2025). Coordinate-based meta-analysis of brain alterations in disorders of consciousness [Paper presentation]. DOCBOX DAYS.

Sala, A. (2025). Coordinate-based meta-analysis of brain alterations in disorders of consciousness [Paper presentation]. GIGA Consciousness Day.

Sala, A. (2025). Advances and future perspectives in positron emission tomography applied to disorders of consciousness [Paper presentation]. GIGA Neuroscience Day.

Sala, A., Gosseries, O., Laureys, S., & Annen, J. (2025). Advances in neuroimaging in disorders of consciousness. In Handbook of Clinical Neurology: Coma, Stupor, and Related Disorders of Consciousness. Elsevier. doi:10.1016/B978-0-443-13408-1.00008-7

Severino, M., Peretti, D. E., Bardiau, M., Cavaliere, C., Doyen, M., Gonzalez-Escamilla, G., Horowitz, T., Nørgaard, M., Perez, J. A. M., Perovnik, M., Rullmann, M., Steenken, D., Talmasov, D., Tang, C., Volpi, T., Xu, Z., Bertoldo, A., Calhoun, V. D., Caminiti, S. P., ... Veronese, M. (2025). Molecular connectivity studies in neurotransmission: a scoping review. Imaging Neuroscience, 3. doi:10.1162/imag_a_00530

Sanz, L., Lejeune, N., Szymkowicz, E., Bonin, E., Panda, R., Sala, A., Thibaut, A., Huerta-Gutierrez, R., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Stender, J., Farber, N. M., Zafonte, R. D., Schiff, N. D., Laureys, S., & Gosseries, O. (December 2024). Apomorphine for prolonged disorders of consciousness: a multimodal open-label study. EClinicalMedicine, 78, 102925. doi:10.1016/j.eclinm.2024.102925

Rogeau, A., Boer, A. J., Guedj, E., Sala, A., Sommer, I. E., Veronese, M., van der Weijden-Germann, M., EANM Neuroimaging Committee, & Fraioli, F. (2024). EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-024-06987-1

Mastenbroek, S. E.* , Sala, A.* , Vállez García, D., Shekari, M., Salvadó, G., Lorenzini, L., Pieperhoff, L., Wink, A. M., Lopes Alves, I., Wolz, R., Ritchie, C., Boada, M., Visser, P. J., Bucci, M., Farrar, G., Hansson, O., Nordberg, A. K., Ossenkoppele, R., Barkhof, F., ... Alzheimer's Disease Neuroimaging Initiative on behalf of the AMYPAD consortium. (09 July 2024). Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity. Neurology, 103 (1), 209419. doi:10.1212/WNL.0000000000209419

Cecconi, B., van der Lande, G., & Sala, A. (2024). Neural Correlates of Consciousness. In Coma and Disorders of Consciousness. Springer. doi:10.1007/978-3-031-50563-8_1

Lizarraga, A., Ripp, I., Sala, A., Shi, K., Düring, M., Koch, K., & Yakushev, I. (2024). Similarity between structural and proxy estimates of brain connectivity. Journal of Cerebral Blood Flow and Metabolism, 271678X231204769. doi:10.1177/0271678X231204769

Meys, M., Wang, Z., Abagnale, S., Ok, B. K., Alnagger, N., Bardiau, M., Beaudart, C., Laureys, S., Gosseries, O., Thibaut, A., Sala, A., & Annen, J. (2024). Global neurophysiological measures in disorders of consciousness: a meta-analysis [Paper presentation]. EAN, Budapest, Hungary.

Sala, A. (2024). What is molecular imaging? [Paper presentation]. OHBM, Seoul, South Korea.

Sala, A. (2024). Multi-modal neurophysiological techniques to assess patients with disorders of consciousness - PET [Paper presentation]. ASSC, Tokyo, Japan.

Sala, A. (2024). Brain PET imaging 2.0. How can molecular imaging capture brain connectivity? [Paper presentation]. EANM, Hambourg, Germany.

Sala, A. (2024). Assessing residual brain function in DoC patients with Positron Emission Tomography [Paper presentation]. DOCBOX DAYS.

Imarisio, A., Pilotto, A., Premi, E., Caminiti, S. P., Presotto, L., Sala, A., Zatti, C., Lupini, A., Turrone, R., Paghera, B., Borroni, B., Perani, D., & Padovani, A. (October 2023). Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease. Parkinsonism and Related Disorders, 115, 105848. doi:10.1016/j.parkreldis.2023.105848

Annen, J., Frasso, G., van der Lande, G., Bonin, E., Vitello, M., Panda, R., Sala, A., Cavaliere, C., Raimondo, F., Bahri, M. A., Schiff, N. D., Gosseries, O., Thibaut, A., & Laureys, S. (26 July 2023). Cerebral electrometabolic coupling in disordered and normal states of consciousness. Cell Reports, 42 (8), 112854. doi:10.1016/j.celrep.2023.112854

Meys, M., Wang, Z., Abagnale, S., Kaan, B., Alnagger, N., Bardiau, M., Beaudart, C., Laureys, S., Gosseries, O., Thibaut, A., Annen, J., & Sala, A. (25 July 2023). A Meta-Analysis of Global Neurophysiological Measures in Disorders of Consciousness [Poster presentation]. 29th Annual Meeting of the Organization for Human Brain Mapping, Montreal, Canada.

Meys, M., Danuta, S., Wang, Z., Abagnale, S., Kaan, B., Alnagger, N., Bardiau, M., Kói, T., Beaudart, C., Laureys, S., Gosseries, O., Thibaut, A., Sala, A., & Annen, J. (23 June 2023). Disorders of Consciousness through Global Neurophysiological Measures: a Meta-Analysis [Paper presentation]. 26th Annual Meeting of the Association for the Scientific Study of Consciousness, New York, United States.

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Laureys, S., & Gosseries, O. (01 April 2023). Multimodal open-label study of apomorphine in disorders of consciousness [Paper presentation]. 14th Biennial World Congress on Brain Injury, Dublin, Ireland.

Sala, A., Lizarraga, A., Caminiti, S. P., Calhoun, V. D., Eickhoff, S. B., Habeck, C., Jamadar, S. D., Perani, D., Pereira, J. B., Veronese, M., & Yakushev, I. (2023). Brain connectomics: time for a molecular imaging perspective? Trends in Cognitive Sciences. doi:10.1016/j.tics.2022.11.015

Leandro, S., Selte, A., Andris, C., Thibaut, A., Bonin, E., Larroque, S., Bernard, C., Hustinx, R., Laureys, S., Sala, A., & Gosseries, O. (2023). Visual deficits and occipital metabolism correlate with levels of consciousness in severe brain injury [Paper presentation]. World Congress on Brain Injury, Ireland.

Lizarraga, A., Sala, A., Ripp, I., Koch, K., & Yakushev, I. (2023). Test-retest reproducibility of common estimates of brain connectivity [Paper presentation]. Resting State Brain Connectivity Conference.

Meys, M., Wang, Z., Abagnale, S., Kaan, B. O., Alnagger, N., Bardiau, M., Beaudart, C., Laureys, S., Gosseries, O., Thibaut, A., Sala, A., & Annen, J. (2023). Global Neurophysiological Measures in Disorders of Consciousness: a MetaAnalysis. European Journal of Neurology, Supplement 1, 120-87.

Sala, A. (2023). Molecular imaging and brain connectomics: present and future of molecular connectivity [Paper presentation]. Brain & Brain PET, Brisbane, Australia.

Sala, A. (2023). Methods in molecular connectivity: getting at the single-subject level [Paper presentation]. Sinapsa Neuroscience Conference, Ljublijana, Slovenia.

Sala, A., Herfert, K., Gonzalez-Escamilla, G., Caminiti, S. P., & Bertoglio, D. (2023). Editorial: Imaging brain molecular connectivity in health and disease. Frontiers in Human Neuroscience, 17, 1298382. doi:10.3389/fnhum.2023.1298382

Sala, A., Kaan, B. O., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). Neural correlates of consciousness: a coordinate-based meta-analysis of brain alterations in disorders of consciousness [Paper presentation]. 26th Annual Meeting of the Association for the Scientific Study of Consciousness.

Sala, A., Kaan, B., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). Brain alterations in disorders of consciousness: a coordinate-based metaanalysis. European Journal of Neurology, 30 (Supplement 1), 120-187.

Sala, A., Kaan, B. O., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). A coordinate-based meta-analysis of brain alterations in disorders of consciousness [Paper presentation]. OHBM.

Sala, A., Ok, B. K., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). Brain alterations in disorders of consciousness: a coordinate-based meta-analysis [Paper presentation]. EAN.

Sala, A., Schindele, A., Beliy, N., Bernard, C., Panda, R., Phillips, C., Bahri, M. A., Hustinx, R., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). Development of an Automated Pipeline for the Analysis of [18F]FDG-PET Images in Disorders of Consciousness [Paper presentation]. IBIA, Dublin, Ireland.

Sanz, L., Selte, A., Andris, C., Thibaut, A., Bonin, E., Larroque, S., Bernard, C., Hustinx, R., Laureys, S., Sala, A., & Gosseries, O. (2023). Visual deficits and occipital metabolism correlate with levels of consciousness in severe brain injury [Paper presentation]. IBIA, Dublin, Ireland.

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Laureys, S., & Gosseries, O. (06 September 2022). Apomorphine dopaminergic neuromodulation in severe brain- injured patients with consciousness disorders – a pilot study [Paper presentation]. GIGA day 2022, Liège, Belgium.

Cacciaglia, R., Salvadó, G., Molinuevo, J. L., Shekari, M., Falcon, C., Operto, G., Suárez-Calvet, M., Milà-Alomà, M., Sala, A., Rodriguez-Vieitez, E., Kollmorgen, G., Suridjan, I., Blennow, K., Zetterberg, H., Gispert, J. D., Alzheimer’s Disease Neuroimaging Initiative, & ALFA study. (April 2022). Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts. Molecular Psychiatry, 27 (4), 2010 - 2018. doi:10.1038/s41380-022-01436-7

Sala, A. (2022). PET for brain connectivity [Paper presentation]. Giornata Mondiale per l'Alzheimer.

Sala, A. (2022). Lifelong bilingualism and mechanisms of neuroprotection in Alzheimer dementia. Human Brain Mapping. doi:10.1002/hbm.25605

Sala, A. (2022). Emerging database of accessible positron emission tomography data of the brain [Paper presentation]. Brain & Brain PET, Glasgow, United Kingdom.

Sala, A. (2022). An automated FDG-PET pipeline for the analysis of glucose brain metabolism in disorders of consciousness. Journal of Cerebral Blood Flow and Metabolism, 42 (1 suppl), 108 - 273. doi:10.1177/0271678X221096357

Sala, A., Lizarraga, A., Ripp, I., Cumming, P., & Yakushev, I. (2022). Static versus Functional PET: Making Sense of Metabolic Connectivity. Cerebral Cortex. doi:10.1093/cercor/bhab271

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., LEDOUX, D., HUSTINX, R., LAUREYS, S., & Gosseries, O. (2022). Investigation of apomorphine-related neural mechanisms in severe brain-injured patients with prolonged disorders of consciousness [Paper presentation]. 25th annual meeting of the ASSC, Amsterdam, Netherlands.

Sanz, L., Lejeune, N., Bonin, E., Panda, R., Sala, A., Dikenstein, D., Farber, N., Thibaut, A., Laureys, S., & Gosseries, O. (29 July 2021). Increased brain metabolism and EEG connectivity after apomorphine therapy in patients with chronic disorders of consciousness [Poster presentation]. the 2021 Virtual World Congress on Brain Injury.

Sanz, L., Lejeune, N., Bonin, E., Panda, R., Sala, A., Dikenstein, D., Farber, N., Thibaut, A., Laureys, S., & Gosseries, O. (01 June 2021). Apomorphine therapy for patients with disorders of consciousness: a multimodal open-label study [Paper presentation]. 7th Congress of the European Academy of Neurology.

Annen, J., Sala, A., Bonin, E., Sanz, L., Barra, A., Cecconi, B., Vitello, M., Szymkowicz, E., Cardone, P., BERNARD, C., Martial, C., LAUREYS, S., Gosseries, O., & Thibaut, A. (2021). FDG-PET/CT data of healthy volunteers and patients with disorders of consciousness. doi:10.25493/7TXP-WCF

Caminiti, S. P., Sala, A., Presotto, L., Chincarini, A., Sestini, S., Perani, D., Schillaci, O., Berti, V., Calcagni, M. L., Cistaro, A., Morbelli, S., Nobili, F., Pappatà, S., Volterrani, D., & Gobbo, C. L. (2021). Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-05175-1

Sala, A. (2021). PET connectivity [Paper presentation]. Brainhack Nordic.

Sala, A. (2021). Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity [Paper presentation]. AAIC.

Sala, A. (2021). In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases. Alzheimer's Research and Therapy. doi:10.1186/s13195-021-00925-1

Sala, A. (2021). A meta-analysis of brain glucose hypo-metabolism in patients with disorders a of consciousness [Paper presentation]. EANM.

Sala, A., Annen, J., Thibaut, A., & LAUREYS, S. (2021). Disturbance of brain glucose metabolism in disorders of consciousness: a meta-analysis. Journal of Nuclear Medicine.

Sala, A., Kaan Ok, B., Thibaut, A., Gosseries, O., LAUREYS, S., & Annen, J. (2021). A meta-analysis of brain glucose hypo-metabolism in patients with disorders of consciousness. European Journal of Nuclear Medicine and Molecular Imaging.

Carli, G., Caminiti, S. P., Sala, A., Galbiati, A., Pilotto, A., Ferini-Strambi, L., Padovani, A., & Perani, D. (2020). Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum. Parkinsonism and Related Disorders, 81, 113-122. doi:10.1016/j.parkreldis.2020.10.036

Catricalà, E., Polito, C., Presotto, L., Esposito, V., Sala, A., Conca, F., Gasparri, C., Berti, V., Filippi, M., Pupi, A., Sorbi, S., Iannaccone, S., Magnani, G., Cappa, S. F., & Perani, D. (2020). Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study. Neurology. doi:10.1212/WNL.0000000000010967

Iaccarino, L.* , Sala, A.* , Caminiti, S. P., Presotto, L., & Perani, D. (2020). In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease. Journal of Alzheimer's Disease, 75 (3), 1003-1016. doi:10.3233/JAD-190954

Perini, G., Rodriguez-Vieitez, E., Kadir, A., Sala, A., Savitcheva, I., & Nordberg, A. (2020). Clinical impact of (18)F-FDG-PET among memory clinic patients with uncertain diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-04969-7

Sala, A. (2020). Imaging dopamine transporter activity in Alzheimer's disease: a molecular connectivity study [Paper presentation]. 8th Winter Seminar on Dementia, Bressanone, Italy.

Sala, A. (2020). Bilingualism modulates brain reserve and resting-state network connectivity [Paper presentation]. 8th Winter Seminar on Dementia, Bressanone, Italy.

Sala, A., Caprioglio, C., Santangelo, R., Vanoli, E. G., Iannaccone, S., Magnani, G., & Perani, D. (2020). Brain metabolic signatures across the Alzheimer's disease spectrum. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 256-269. doi:10.1007/s00259-019-04559-2

Sala, A., Nordberg, A., & Rodriguez-Vieitez, E. (2020). Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity. Molecular Psychiatry. doi:10.1038/s41380-020-00950-w

Santangelo, R., Masserini, F., Agosta, F., Sala, A., Caminiti, S. P., Cecchetti, G., Caso, F., Martinelli, V., Pinto, P., Passerini, G., Perani, D., Magnani, G., & Filippi, M. (2020). CSF p-tau/Aβ(42) ratio and brain FDG-PET may reliably detect MCI "imminent" converters to AD. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-04853-4

Caminiti, S. P.* , Sala, A.* , Iaccarino, L.* , Beretta, L., Pilotto, A., Gianolli, L., Iannaccone, S., Magnani, G., Padovani, A., Ferini-Strambi, L., & Perani, D. (2019). Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimer's Research and Therapy, 11 (1), 20. doi:10.1186/s13195-019-0473-4

Iaccarino, L., Sala, A., & Perani, D. (2019). Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Annals of Clinical and Translational Neurology, 6 (6), 1113-1120. doi:10.1002/acn3.782

Malpetti, M., Carli, G., Sala, A., Cerami, C., Marcone, A., Iannaccone, S., Magnani, G., & Perani, D. (2019). Variant-specific vulnerability in metabolic connectivity and resting-state networks in behavioural variant of frontotemporal dementia. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 120, 483-497. doi:10.1016/j.cortex.2019.07.018

Sala, A. (2019). Longitudinal investigation of concordant and discordant amyloid CSF/PET biomarkers reveals CSF-first and PET-first pathways of amyloid accumulation [Paper presentation]. Alzheimer’s Association International Conference, Los Angeles, United States.

Sala, A. (2019). Longitudinal investigation of concordant and discordant amyloid CSF/PET biomarkers [Paper presentation]. Human Amyloid Imaging Conference, Miami, United States.

Sala, A. (2019). Dopaminergic dysfunction in the ventrotegmental-mesocortical pathways in AD: a structural and molecular imaging study [Paper presentation]. 18th National Congress of the Italian Society for Neuroscience, Perugia, Italy.

Sala, A. (2019). Discordance of CSF and PET markers for amyloidosis: a longitudinal study [Paper presentation]. 7th Winter Seminar on Dementia, Bressanone, Italy.

Sala, A. (2019). Concordant and discordant amyloid CSF/PET biomarkers in Alzheimer’s disease: a longitudinal investigation [Paper presentation]. Swedish Meeting for Alzheimer’s research, Stockholm, Sweden.

Sala, A., Caminiti, S. P., Iaccarino, L., Beretta, L., Iannaccone, S., Magnani, G., Padovani, A., Ferini-Strambi, L., & Perani, D. (2019). Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies. Human Brain Mapping, 40 (15), 4537-4550. doi:10.1002/hbm.24719

Sala, A., Iaccarino, L., Fania, P., Vanoli, E. G., Fallanca, F., Pagnini, C., Cerami, C., Calvo, A., Canosa, A., Pagani, M., Chiò, A., Cistaro, A., & Perani, D. (2019). Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. European Journal of Nuclear Medicine and Molecular Imaging, 46 (5), 1117-1131. doi:10.1007/s00259-018-4246-2

Sala, A., Malpetti, M., Ferrulli, A., Gianolli, L., Luzi, L., & Perani, D. (2019). High body mass index, brain metabolism and connectivity: an unfavorable effect in elderly females. Aging, 11 (19), 8573-8586. doi:10.18632/aging.102347

Sala, A., & Perani, D. (2019). Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography. Frontiers in Neuroscience, 13, 617. doi:10.3389/fnins.2019.00617

Santangelo, R., Dell'Edera, A., Sala, A., Cecchetti, G., Masserini, F., Caso, F., Pinto, P., Leocani, L., Falautano, M., Passerini, G., Martinelli, V., Comi, G., Perani, D., & Magnani, G. (2019). The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia. Current Alzheimer Research, 16 (7), 587-595. doi:10.2174/1567205016666190725150836

Caminiti, S. P., Ballarini, T., Sala, A., Cerami, C., Presotto, L., Santangelo, R., Fallanca, F., Vanoli, E. G., Gianolli, L., Iannaccone, S., Magnani, G., & Perani, D. (2018). FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage: Clinical, 18, 167-177. doi:10.1016/j.nicl.2018.01.019

Iaccarino, L., Sala, A., Caminiti, S. P., Santangelo, R., Iannaccone, S., Magnani, G., & Perani, D. (2018). The brain metabolic signature of visual hallucinations in dementia with Lewy bodies. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 108, 13-24. doi:10.1016/j.cortex.2018.06.014

Malpetti, M., Sala, A., Vanoli, E. G., Gianolli, L., Luzi, L., & Perani, D. (2018). Unfavourable gender effect of high body mass index on brain metabolism and connectivity. Scientific Reports, 8 (1), 12584. doi:10.1038/s41598-018-30883-y

Presotto, L., Iaccarino, L., Sala, A., Vanoli, E. G., Muscio, C., Nigri, A., Bruzzone, M. G., Tagliavini, F., Gianolli, L., Perani, D., & Bettinardi, V. (2018). Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification. NeuroImage: Clinical, 20, 153-160. doi:10.1016/j.nicl.2018.07.013

Sala, A. (2018). Multi-network signature reflects clinical heterogeneity in Lewy body dementia [Paper presentation]. European Conference on Clinical Neuroimaging, Bruxelles, Belgium.

Sala, A. (2018). Long-term clinical stability in amyloid-positive subjects is predicted by negative FDG-PET scan [Paper presentation]. XII National SINDEM Meeting, Florence, Italy.

Caminiti, S. P., Tettamanti, M., Sala, A., Presotto, L., Iannaccone, S., Cappa, S. F., Magnani, G., & Perani, D. (2017). Metabolic connectomics targeting brain pathology in dementia with Lewy bodies. Journal of Cerebral Blood Flow and Metabolism, 37 (4), 1311-1325. doi:10.1177/0271678X16654497

Iaccarino, L., Sala, A., Caminiti, S. P., & Perani, D. (2017). The emerging role of PET imaging in dementia. F1000Research, 6, 1830. doi:10.12688/f1000research.11603.1

Sala, A. (2017). Visual hallucinations in dementia with Lewy bodies: a brain FDG-PET metabolic study [Paper presentation]. European Conference on Clinical Neuroimaging, Rome, Italy.

Sala, A. (2017). Body mass index and Alzheimer’s dementia: an unfavourable gender effect on brain metabolism and connectivity [Paper presentation]. 4th National Congress on Gender Medicine, Padua, Italy.

Sala, A. (2017). Altered resting state network topographies in Dementia with Lewy Bodies [Paper presentation]. 5th winter seminar on Dementia, Bressanone, Italy.

Sala, A., Caminiti, S. P., Presotto, L., Premi, E., Pilotto, A., Turrone, R., Cosseddu, M., Alberici, A., Paghera, B., Borroni, B., Padovani, A., & Perani, D. (2017). Altered brain metabolic connectivity at multiscale level in early Parkinson's disease. Scientific Reports, 7 (1), 4256. doi:10.1038/s41598-017-04102-z

Sala, A. (2016). Metabolic connectomics targeting brain pathology in Dementia with Lewy Bodies [Paper presentation]. 4th winter seminar on Dementia, Bressanone, Italy.